Skip to main content
AXP
NYSE Finance

American Express Consents to Fed and OCC Orders Over AML Deficiencies; $350M Penalty

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Credit Services Stocks · Financial
Sentiment info
Negative
Importance info
8
Price
$305.51
Mkt Cap
$208.063B
52W Low
$290.967
52W High
$387.49
52W Position info
5.0% above low
Off High info
21% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

AXP is trading near its 52-week low of $290.967 (5.0% above the low).

Summary

American Express consented to Federal Reserve and OCC orders over financial crimes compliance deficiencies, including a $350 million OCC penalty. The company says the penalty does not affect 2026 guidance and the orders do not impose an asset cap.


Key Events · Legal and Risk Events · AXP

  • Dual Regulator Consent Orders

    American Express Company and American Express Travel Related Services consented to a Federal Reserve order, while American Express National Bank consented to an OCC order, resolving previously disclosed reviews of the financial crimes compliance program.

  • $350M Civil Money Penalty

    AENB agreed to pay a $350 million civil money penalty to the OCC. A portion was reserved in prior periods, and the company states it does not impact full-year 2026 guidance.

  • No Asset Cap Imposed

    The consent orders do not impose an asset cap on the company, a key relief for investors concerned about growth restrictions.

  • 2027 Guidance Unaffected

    Costs associated with addressing the consent order requirements are not anticipated to affect the company's 2027 guidance.


Analysis · AXP · Finance

American Express disclosed consent orders from both the Federal Reserve and the OCC resolving previously disclosed reviews of its financial crimes compliance program. The OCC imposed a $350 million civil money penalty, but the company stated the penalty was partially reserved and does not affect full-year 2026 guidance. The orders do not impose an asset cap, and remediation costs are not expected to affect 2027 guidance. The dual-regulator action signals heightened scrutiny of the company's AML controls, though the financial impact appears manageable.

How filings like this one have moved

In the 30 days to Oct 8, 2026, 36.3% of the 1065 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AXP was trading at $305.51 on NYSE in the Finance sector, with a market capitalization of approximately $208.1B. The 52-week trading range was $290.97 to $387.49. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AXP - Latest Insights

AXP
Oct 08, 2026, 4:30 PM EDT
Source: Reuters
Importance Score:
8
AXP
Jul 24, 2026, 12:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
AXP
Jul 24, 2026, 9:55 AM EDT
Source: ShareCast
Importance Score:
7
AXP
Jul 24, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
AXP
Jul 24, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8